創美藥業(02289.HK):張寒孜將作為江藥集團在公司提名/推薦/同意委任的董事
格隆匯4月18日丨創美藥業(02289.HK)公佈,公司董事會已獲知悉,於2023年4月18日,江藥集團有限公司(原名江西江中醫藥商業運營有限責任公司)("江藥集團")作為公司的控股股東,與公司執行董事張寒孜簽訂承諾函,據此,自承諾函簽訂之日起,張寒孜將作為江藥集團在公司提名/推薦/同意委任的董事("江藥集團方董事")。
據承諾函所述,張寒孜承諾在適用法律法規及《香港證券交易所有限公司證券上市規則》允許的最大範圍內(包括履行受信責任及謹慎、熟練和勤奮責任),自承諾函簽訂之日起,其應當作為江藥集團方董事在就與江藥集團有關聯的董事會議案表決的事項進行迴避表決,除此情況以外,非因特殊情況,張寒孜保證出席相關董事會決策會議。如確定無法出席董事會會議,其須委託其他江藥集團方董事參加相關會議行使表決權。但是,前述規定不得損害公司及其少數股東的權益,亦不得損害公司管理層監督公司日常經營的權力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.